We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Diurnal Group Plc | LSE:DNL | London | Ordinary Share | GB00BDB6Q760 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 27.30 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDNL
RNS Number : 6269O
Diurnal Group PLC
18 May 2018
18 May 2018
Diurnal Group plc
("Diurnal" or the "Company")
Director Dealings
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that it has been notified of the following transaction in the Company's ordinary shares undertaken by Alan Raymond, Non-Executive Director, as a result of a re-registration to a nominee account. There has been no change of beneficial ownership as a result of this transfer of legal title.
For further information, please visit www.diurnal.co.uk or contact: +44 (0)20 3727 Diurnal Group plc 1000 Martin Whitaker, Chief Executive Officer Richard Bungay, Chief Financial Officer Panmure Gordon (UK) Limited (Nominated +44 (0) 20 7886 Adviser and Joint Broker) 2500 Corporate Finance: Freddy Crossley, Emma Earl Corporate Broking: James Stearns Cantor Fitzgerald Europe (Joint +44 (0)20 7894 Broker) 7000 Corporate Finance: Phil Davies, Will Goode, Michael Boot Healthcare Equity Sales: Andrew Keith +44 (0)20 3727 FTI Consulting 1000 Simon Conway Victoria Foster Mitchell
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.
For further information about Diurnal, please visit www.diurnal.co.uk
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 Details of the person discharging managerial responsibilities / person closely associated ---- -------------------------------------------------------------------- a) Name Alan Raymond ---- ------------------------------ ------------------------------------ 2 Reason for the notification ---- -------------------------------------------------------------------- a) Position/status Non-executive Director ---- ------------------------------ ------------------------------------ b) Initial notification Initial notification /Amendment ---- ------------------------------ ------------------------------------ 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---- -------------------------------------------------------------------- a) Name Diurnal Group plc ---- ------------------------------ ------------------------------------ b) LEI 213800I2HNUNZN1LDH29 ---- ------------------------------ ------------------------------------ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---- -------------------------------------------------------------------- a) Description of Ordinary shares of 5 pence the financial each in Diurnal Group plc instrument, type of instrument ---- Identification GB00BDB6Q760 code b) Nature of the Re-registration of ordinary transaction shares with Redmayne Bentley Stockbrokers ---- ------------------------------ ------------------------------------ c) Price(s) and volume(s) ---- ---------------- --------------- Price(s) Volume(s) ---- ---------------- --------------- Nil 19,888 ---------------------------------------------------- --------------- d) Aggregated information n/a ---- e) Date of the transaction 14 May 2018 ---- ------------------------------ ------------------------------------ f) Place of the transaction Outside a trading venue ---- ------------------------------ ------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLLFVSELITLIT
(END) Dow Jones Newswires
May 18, 2018 10:33 ET (14:33 GMT)
1 Year Diurnal Chart |
1 Month Diurnal Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions